Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3a9b48084b8620260beac95a10f7359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_097405822d505467fd50f7100022cd56 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-54 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f4091231eb23b2cb9e66d0b112d1c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34e981f8d26055279dc159e4feda0197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7751d956bad54762482fa11e18b3167a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23dcdb2d2afceafbc20580d8f3378b1b |
publicationDate |
2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018214528-A1 |
titleOfInvention |
Pharmaceutical composition for inhibiting expression of cd47 in tumor cells and use of same |
abstract |
The pharmaceutical composition for inhibiting expression of CD47 in tumor cells provided by the present invention contains:n exosomes produced by cultured tumor cells in an amount effective for inhibiting expression of the CD47; and a pharmaceutically acceptable carrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021184022-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114958722-A |
priorityDate |
2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |